Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Jan 27, 2025; 17(1): 100130
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.100130
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.100130
Table 1 Analysis of clinical data of gastric carcinoma and precancerous gastric condition groups
Clinical data | Precancerous gastric condition (n = 134) | GC (n = 133) | χ2/t | P value |
Gender, n (%) | 9.504 | 0.002 | ||
Male | 69 (51.49) | 93 (69.92) | ||
Female | 65 (48.51) | 40 (30.08) | ||
Age (year) | 61.76 ± 9.31 | 66.27 ± 10.54 | 3.706 | < 0.001 |
BMI (kg/m2) | 23.45 ± 3.01 | 22.26 ± 3.20 | 3.130 | 0.002 |
Neutrophil count | 2.64 ± 0.78 | 3.44 ± 1.28 | 6.172 | < 0.001 |
Lymphocyte count | 1.88 ± 0.56 | 1.87 ± 0.55 | 0.147 | 0.883 |
Platelet count | 199.46 ± 51.28 | 235.90 ± 76.38 | 4.580 | < 0.001 |
- Citation: Wu HM, Ying XX, Lv LL, Hu JW. Diagnostic implications of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammatory index for gastric carcinoma. World J Gastrointest Surg 2025; 17(1): 100130
- URL: https://www.wjgnet.com/1948-9366/full/v17/i1/100130.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i1.100130